Matson Inc
NYSE:MATX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Matson Inc
NYSE:MATX
|
US |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
Multiples-Based Value
The Multiples-Based Value for
Matson Inc (MATX) under the Base Case is 140.447 USD.
Compared with the current market price of 202.675 USD, the stock appears
Overvalued by 31% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.